Prediction of lithium response. 1979

J Ananth, and F Engelsmann, and R Kiriakos, and T Kolivakis

Even though lithium has been established as an effective agent in the management of primary affective disorders, not all manic-depressive patients respond favourably to lithium therapy. Therefore we attempted to delineate lithium responders from non-responders in a group of 54 manic-depressive patients on the basis of an assessment which included 64 variables and the results showed that only two thirds were pure responders. Females, patients with prior manic episodes, onset of the illness initially with a manic episode, and premorbid psychothymic personality were all indicators of favourable long-term lithium response. Patients with retarded depression, severe anxiety, though disorder and those with higher scores on the Psychopathic Deviate and Paranoia scales of the MMPI were poor lithium responders. It should be noted, however, that only a few of the differences between responders and non-responders were statistically significant. Our study suggests a number of predictive variables for the identification of lithium responders.

UI MeSH Term Description Entries
D008094 Lithium An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER. Lithium-7,Lithium 7
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008950 MMPI A personality inventory consisting of statements to be asserted or denied by the individual. The patterns of response are characteristic of certain personality attributes. Minnesota Multiphasic Personality Inventory
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

J Ananth, and F Engelsmann, and R Kiriakos, and T Kolivakis
January 1979, Comprehensive psychiatry,
J Ananth, and F Engelsmann, and R Kiriakos, and T Kolivakis
February 2020, Acta psychiatrica Scandinavica,
J Ananth, and F Engelsmann, and R Kiriakos, and T Kolivakis
January 2021, Scientific reports,
J Ananth, and F Engelsmann, and R Kiriakos, and T Kolivakis
November 1983, Pharmacopsychiatria,
J Ananth, and F Engelsmann, and R Kiriakos, and T Kolivakis
February 1978, The Journal of clinical psychiatry,
J Ananth, and F Engelsmann, and R Kiriakos, and T Kolivakis
January 1984, Adolescence,
J Ananth, and F Engelsmann, and R Kiriakos, and T Kolivakis
March 2000, The international journal of neuropsychopharmacology,
J Ananth, and F Engelsmann, and R Kiriakos, and T Kolivakis
January 1986, Journal of affective disorders,
J Ananth, and F Engelsmann, and R Kiriakos, and T Kolivakis
January 2000, International clinical psychopharmacology,
J Ananth, and F Engelsmann, and R Kiriakos, and T Kolivakis
February 1988, Journal of clinical psychopharmacology,
Copied contents to your clipboard!